≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Injury of blood vessels at ankle and foot level

Endpoint Browser

ST19_INJURY_BLOOD_VESSE_ANKLE_FOOT_LEVEL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — S95
  • Cause of death: ICD-10 — S95

2 out of 7 registries used, show all original rules.

41

4. Check minimum number of events

None

41

5. Include endpoints

None

41

6. Filter based on genotype QC (FinnGen only)

41

Control definitions (FinnGen only)

Control exclude
ST19_INJURI_ANKLE_FOOT

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
S90
Name in latin
Laesio vasorum sanguineorum in regione tarsi/pedis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 41 17 24
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 52.43 57.19 49.06

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042936) Bacteria identified in Isolate by Culture
13
36
4.82
4.64
2.2
3.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
10
27
4.58
3.60
1.2
2.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
22
106
3.32
3.47
2.7
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
32
201
3.69
3.34
2.7
4.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
11
35
3.93
3.20
5.4
20.5
kpa
5.1
4.9
0.41
11
35
(3027801) Oxygen [Partial pressure] in Arterial blood
11
35
3.93
3.20
5.4
20.6
kpa
13.6
12.5
0.21
11
35
(3032080) INR in Blood by Coagulation assay
24
128
3.11
3.10
18.5
10.5
inr
1.2
1.2
—
7
34
(3035350) Ketones [Presence] in Urine by Test strip
27
155
3.17
3.05
2.5
3.9
estimate
0.0
0.0
—
8
28
(3021601) Nitrite [Presence] in Urine by Test strip
27
155
3.17
3.05
3.1
5.4
estimate
0.0
0.0
—
7
27
(3014007) Fractional oxyhemoglobin in Arterial blood
9
23
4.71
2.98
5.4
9.0
%
91.8
94.7
—
9
23
(3009261) Glucose [Presence] in Urine by Test strip
27
157
3.11
2.95
2.5
3.9
estimate
0.0
0.0
—
8
24
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
24
131
3.01
2.93
2.2
3.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
15
5.39
2.73
5.3
4.3
mmol/l
25.7
25.1
—
7
15
(3014111) Lactate [Moles/volume] in Serum or Plasma
9
27
3.97
2.58
7.4
7.4
mmol/l
1.0
1.1
—
9
27
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
24
138
2.78
2.56
10.1
9.9
mmol/l
1.2
1.2
0.64
19
112
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
22
4.25
2.52
6.0
9.1
%
1.7
1.5
—
8
22
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
22
4.25
2.52
6.0
9.1
%
0.7
0.9
—
8
22
(3014576) Chloride [Moles/volume] in Serum or Plasma
11
41
3.30
2.51
7.3
7.5
mmol/l
105.6
103.1
0.99
11
41
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
6
12
5.65
2.50
7.5
13.8
mmol/l
23.8
24.1
—
6
12
(3018095) Leukocytes [#/volume] in Urine
19
99
2.71
2.42
3.2
3.3
e6/l
9.4
53.0
0.75
14
78
(3000991) Gas panel - Venous blood
8
23
4.06
2.42
10.5
9.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
16
78
2.72
2.30
2.9
2.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
9
31
3.42
2.24
6.2
23.1
g/l
127.2
125.8
—
9
31
(3016502) Oxygen saturation in Arterial blood
9
33
3.20
2.08
6.2
21.8
%
96.1
96.9
—
9
33
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
21
3.80
2.07
1.1
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
34
254
2.98
2.01
29.1
18.4
%
13.7
13.6
0.24
34
248
(3037522) Nuclear Ab [Titer] in Serum
10
40
2.98
2.01
1.1
1.3
—
470.0
—
0
12
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
11
5.01
2.00
6.4
59.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
17
91
2.48
1.99
9.2
3.6
ph
7.4
7.4
—
5
17
(3029937) Albumin [Presence] in Urine by Test strip
17
92
2.45
1.93
2.6
3.5
estimate
0.0
0.0
—
8
25
(40761536) Microorganisms panel - Urine sediment
7
25
3.16
1.74
3.0
2.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
16
89
2.31
1.68
2.1
2.8
—
—
—
0
0
(3000492) Spirometry study
8
33
2.76
1.64
1.3
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
15
82
2.31
1.63
4.4
5.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
14
76
2.28
1.53
2.4
4.5
—
—
—
0
0
(3002256) Pathology report gross observation
7
28
2.80
1.53
2.1
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
17
101
2.17
1.50
3.9
5.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
5
16
3.41
1.48
1.4
3.3
mmol/l
1.0
1.5
—
5
16
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
29
2.70
1.46
1.7
1.5
—
—
—
0
0
(3012544) pH of Venous blood
7
29
2.70
1.46
6.9
3.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
12
63
2.28
1.40
2.8
2.8
—
—
—
0
0
(4035726)
5
17
3.20
1.40
1.0
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
15
88
2.11
1.35
2.9
2.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
5
18
3.01
1.32
4.2
1.7
%
0.5
0.8
—
5
18
(3015736) pH of Urine
19
123
2.02
1.31
2.4
3.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
6
25
2.63
1.29
2.3
22.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
30
231
2.11
1.26
4.4
3.8
mm/h
13.7
11.0
0.40
30
215
(40760892) CBC W Ordered Manual Differential panel - Blood
14
82
2.07
1.25
2.6
4.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
20
2.70
1.18
4.2
1.7
%
0.9
1.4
—
5
20
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
31
2.51
1.17
2.0
1.7
—
—
—
0
0
(3020891) Body temperature
5
21
2.57
1.12
2.8
3.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
7
33
2.35
1.12
1.3
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
13
80
1.92
0.99
1.9
4.9
—
1.0
—
0
5
(3007853) Bacteria identified in Skin by Aerobe culture
8
42
2.12
0.96
3.0
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
30
2.17
0.91
4.8
4.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
9
53
1.89
0.83
3.9
3.9
mmol/l
2.5
2.4
—
9
46
(3022145) Colonoscopy Study observation
6
33
1.95
0.82
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
24
0.00
0.82
0.0
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
14
94
1.74
0.80
1.5
3.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
19
140
1.67
0.78
4.8
4.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
5
24
2.23
0.77
3.8
24.9
mmol/l
24.8
23.9
—
5
24
(3044889) 12 lead EKG panel
27
219
1.68
0.76
5.3
4.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7
40
1.90
0.76
2.0
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
15
106
1.65
0.71
2.1
2.1
pmol/l
92.0
101.4
—
6
47
(40758558) Short blood count panel - Blood
11
71
1.75
0.71
9.3
6.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
63
1.78
0.69
1.2
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
19
144
1.60
0.68
4.7
5.6
%
2.9
2.9
0.01
19
133
(3022948) Iron [Moles/volume] in Serum or Plasma
8
49
1.78
0.67
4.0
2.0
umol/l
16.0
13.6
—
8
43
(3019069) Monocytes/100 leukocytes in Blood
19
146
1.56
0.63
4.8
6.0
%
8.1
8.6
0.31
19
134
(3013512) EKG study
13
91
1.63
0.63
3.0
4.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
24
195
1.56
0.62
2.8
2.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
19
150
1.50
0.54
4.7
5.5
%
50.3
56.3
1.76
19
140
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
20
160
1.49
0.53
5.1
8.4
umol/l
11.2
10.6
0.14
20
150
(40768804) Tissue Pathology biopsy report
15
113
1.52
0.53
2.8
2.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
18
142
1.48
0.51
4.9
5.7
%
0.7
0.8
0.16
18
129
(3013826) Glucose [Moles/volume] in Serum or Plasma
23
192
1.45
0.48
6.7
7.2
mmol/l
7.4
6.6
0.61
23
175
(40761535) Cells panel - Urine sediment
5
33
1.58
0.43
1.4
2.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
33
1.58
0.43
1.4
2.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
17
137
1.41
0.41
4.9
5.6
g/l
35.6
36.3
0.18
17
130
(3004789) Transferrin [Mass/volume] in Serum or Plasma
6
42
1.50
0.37
5.0
2.1
g/l
2.0
2.3
—
6
37
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
6
43
1.46
0.37
5.3
2.0
%
23.0
23.5
—
6
33
(3009542) Hematocrit [Volume Fraction] of Blood
31
283
1.39
0.31
31.1
16.0
%
41.4
40.6
0.28
22
219
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
4.4
—
0.5
—
0
11
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
6.5
—
40.4
—
0
11
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
4.4
—
0.0
—
0
11
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
4.2
—
9.8
—
0
11
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
4.5
—
0.0
—
0
10
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
4.5
—
38.0
—
0
10
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
4.5
—
0.0
—
0
10
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
4.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
11
91
1.29
0.20
4.5
4.2
%
24.4
19.6
—
6
38
(3003694) ABO and Rh group [Type] in Blood
7
84
0.80
0.16
1.1
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
13
115
1.19
0.12
3.8
2.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
12
113
1.09
0.02
8.0
4.8
ug/l
3.1
4.7
0.20
12
101
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
59.0
—
0
5
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.7
—
107.3
—
0
6
(40760888) Immunoglobulin light chains.free panel - Serum
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
0
6
0.00
0.00
0.0
1.2
—
20.5
—
0
6
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
3.3
—
0
6
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
8
78
1.03
0.00
2.4
2.4
umol/l
433.5
5004.1
—
8
65
(3004616) Nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.7
—
3.9
—
0
6
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
3.9
—
0
8
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
4.3
—
33.7
—
0
8
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.3
—
582.9
—
0
9
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_INJURY_BLOOD_VESSE_ANKLE_FOOT_LEVEL – Injury of blood vessels at ankle and foot level

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).